Oguz Resat Sipahi
Overview
Explore the profile of Oguz Resat Sipahi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
642
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qaedi A, Elbahr U, Abali G, Cakar B, Sencan O, Hejres S, et al.
New Microbiol
. 2025 Feb;
47(4):355-357.
PMID: 39998400
A 66-year-old female, a known case of endometrial serous carcinoma, presented with a history of poor oral intake. Elevated C-reactive protein was identified, and an echocardiogram showed evidence of large...
2.
Sanlidag Isbilen G, Aydin Uysal A, Yigit S, Appak O, Sipahi H, Bozdayi G, et al.
Turk J Med Sci
. 2024 Sep;
54(4):761-765.
PMID: 39295607
Background/aim: Although seasonal human coronaviruses (HCoVs) have long been recognized as respiratory tract viruses, the newly identified SARS-CoV-2 caused a pandemic associated with severe respiratory failure. We aimed to evaluate...
3.
Sahin M, Mert A, Emecen A, Strunjas N, Fasanekova L, Batirel A, et al.
Int J Infect Dis
. 2024 Aug;
147:107228.
PMID: 39216784
Objectives: This study of 331 primary brain abscess (PBA) patients aimed to understand infecting agents, predisposing factors, and outcomes, with a focus on factors affecting mortality. Methods: Data were collected...
4.
Sahin M, Yilmaz M, Mert A, Emecen A, Rahman S Al Maslamani M, Mahmoud A Hashim S, et al.
Heliyon
. 2024 Jul;
10(14):e34325.
PMID: 39082033
Background: This study aimed to identify factors that influence the mortality rate of patients with coronavirus disease (COVID-19)-associated pulmonary aspergillosis (CAPA). Methods: In this cross-sectional study, data from 23 centers...
5.
Sanlidag Isbilen G, Akyol D, Yurtseven T, Ozgiray E, Cagli M, Aydemir S, et al.
Surg Infect (Larchmt)
. 2024 Jul;
25(8):627-631.
PMID: 39056120
Carbapenem-resistant is a common cause of nosocomial meningitis, and it presents a challenge in terms of treatment because of limited therapeutic options. Intravenous tigecycline has been considered a potential salvage...
6.
Khairy A, Hejres S, Elbahr U, Dayyab F, Delos Reyes C, Pastrana J, et al.
New Microbiol
. 2024 Jul;
47(2):152-156.
PMID: 39023524
Herein, we aimed to investigate the antifungal susceptibility pattern of Candida auris clinical strains in our setting Bahrain Oncology Center-King Hamad University Hospital-Bahrain. C. auris strains isolated from different clinical...
7.
Onal U, Akyol Seyhan D, Ketenoglu O, Vahabi M, Baskol Elik D, Memetali S, et al.
Mediterr J Hematol Infect Dis
. 2024 Jul;
16(1):e2024051.
PMID: 38984090
Background: This study aimed to evaluate the epidemiology of septic shock (SS) associated with intraabdominal infections (IAI) as well as associated mortality and efficacy of early source control in a...
8.
Sanlidag Isbilen G, Durusoy Onmus I, Cankayali I, Demirag K, Uyar M, Cicek C, et al.
New Microbiol
. 2024 May;
47(1):47-51.
PMID: 38700883
One of the drugs that has been suggested for the treatment of SARS-CoV-2 infection is tenofovir disoproxil (TDF). Herein, it was aimed to evaluate the outcomes of TDF receiving COVID-19...
9.
Mermer S, Turhan T, Bolat E, Aydemir S, Sipahi H, Sipahi O
Chemotherapy
. 2024 May;
69(3):177-184.
PMID: 38697031
Introduction: Nosocomial meningitis may occur after procedures affecting the central nervous system or following traumatic injury. The causative infectious organism is commonly Staphylococcus aureus, a Gram-positive bacterium. The aim of...
10.
Baskol Elik D, Kaya S, Alkan S, Demirdal T, Sener A, Kaya S, et al.
Sci Rep
. 2024 Mar;
14(1):5218.
PMID: 38433274
This multicentre (22 centres in Turkey) retrospective cohort study aimed to assess the clinical outcomes of patients with neutropenic fever and SARS-CoV-2 positivity. Study period was 15 March 2020-15 August...